Engene Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Engene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Engene Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Engene Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.4M | 781k | 1.73 |